Immunocore Holdings plc Basic Earnings Loss Per Share
Immunocore Holdings plc (IMCR) reported Basic Earnings Loss Per Share of -0.29 GBP/shares for the 3-month period ending 2023-06-30, per its 6-K filed 2023-08-10.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:BasicEarningsLossPerShare · last filed 2023-08-10
- Immunocore Holdings plc basic earnings loss per share for the quarter ending 2023-06-30 was -0.29 GBP/shares.
- Immunocore Holdings plc basic earnings loss per share for the quarter ending 2022-09-30 was 0.13 GBP/shares.
- Immunocore Holdings plc basic earnings loss per share for the quarter ending 2022-06-30 was -0.14 GBP/shares.
- Immunocore Holdings plc basic earnings loss per share for the quarter ending 2021-09-30 was -0.69 GBP/shares.
| Period end | Basic Earnings Loss Per Share 3 month | Basic Earnings Loss Per Share 6 month | Basic Earnings Loss Per Share 9 month | Basic Earnings Loss Per Share 12 month |
|---|---|---|---|---|
| 2023-06-30 | -0.29 GBP/shares 6-K · filed 2023-08-10 | -0.64 GBP/shares 6-K · filed 2023-08-10 | ||
| 2022-12-31 | -0.90 GBP/shares 20-F · filed 2023-03-01 | |||
| 2022-09-30 | 0.13 GBP/shares 6-K/A · filed 2022-11-18 | -0.36 GBP/shares 6-K/A · filed 2022-11-18 | ||
| 2022-06-30 | -0.14 GBP/shares 6-K · filed 2023-08-10 | -0.51 GBP/shares 6-K · filed 2023-08-10 | ||
| 2021-12-31 | -3.10 GBP/shares 20-F · filed 2023-03-01 | |||
| 2021-09-30 | -0.69 GBP/shares 6-K/A · filed 2022-11-18 | -2.19 GBP/shares 6-K/A · filed 2022-11-18 | ||
| 2020-12-31 | -2.79 GBP/shares 20-F · filed 2023-03-01 | |||
| 2019-12-31 | -4.66 GBP/shares 20-F · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |